We are proud to report on our partnership with Medidata. Medidata has served as partner in setting up the digitla landscape around the neoMono trial, the currently largest Immunotherpeutic trial in triple negative breast cancer in cooperation with the academic study group phaon scientitic.
In addition to providing some insight into the partnership with Medidata, the case study outlines the challenges and solutions in times of the Covid-19 pandemic in a case study style fashion.
The case study can be found here: Case Study